Increased circulating Th17 cell populations and elevated CSF osteopontin and IL-17 concentrations in patients with Guillain-Barré syndrome.
Autor(es)Han Rong Kun; Cheng Yue Feng; Zhou Shan Shan; Guo Hong; He Rui Dong; Chi Li Jun; Zhang Li Ming
ResumoGuillain-Barré syndrome (GBS) is an acute post-infectious immune-mediated demyelinating disease of the peripheral nervous system. Th17 cells and osteopontin (OPN) have been implicated in the development of autoimmune diseases, but little is known about their relationship and roles in the pathogenesis of GBS. In this study, we used flow cytometry to evaluate peripheral numbers of Th17, real-time polymerase chain reaction to assay mRNA expression of ROR?t, and enzyme-linked immunosorbent assay to determined OPN and IL-17 concentrations. The frequency of Th17 cells was significantly higher in the peripheral blood of acute-stage GBS patients comparison with other non-inflammatory neurological diseases (OND). In line with these observations, the levels of mRNA expression of ROR?t in peripheral blood mononuclear cells and the concentrations IL-17 in both plasma and cerebrospinal fluid (CSF) were significantly higher in the acute-stage GBS than stable-stage GBS. OPN concentrations were significantly increased in the CSF of acute-stage GBS patients compared to OND. Circulating Th17 cell populations and CSF OPN levels, respectively, are correlated with GBS disability scale scores (GDSs), and there was a positive correlation between them. In summary, our preliminary findings suggest that both Th17 and OPN may be associated with the pathogenesis of GBS.
ImprentaJournal of Clinical Immunology, v. 34, n. 1, p. 94-103, 2014
Identificador do Objeto Digital10.1016/j.jocn.2004.04.006
DescritoresGuillain-Barre Syndrome - Biosynthesis ; Guillain-Barre Syndrome - Cell ; Guillain-Barre Syndrome - Pathogenesis ; Guillain-Barre Syndrome - Proteins ; Guillain-Barre Syndrome - Cytokines ; Guillain-Barre Syndrome - Infectious diseases ; Guillain-Barre Syndrome - Real Time PCR ; Guillain-Barre Syndrome - Immunology ; Guillain-Barre Syndrome - Public health
Data de Publicação:2014